Bimm 110 Section 8 Pset

BIMM 110 Molecular Basis of Human Disease TA: George Chen [email protected] OH: Tu 12:30-1:30 Sierra Summit or by appointment Section: W 4:00-4:50 Center 203

Problem Set 8 Announcements: • Please email me if you have any suggestions for how to organize the final section. • This problem set covers lecture 14 and 15. 1. What is the molecular mechanism by which Gleevec acts on treating Chronic Myelogenous Leukemia? Why is this treatment usually done late in the leukemia's development?

2. A Ras mutation causes what events to occur at the cellular level?

3. In what situation(s) would it be appropriate to treat a patient with Decitabine?

4. Describe how GTP-dependent proteins are activated or inactivated.

5. How is Myc overexpressed in Burkitt's Lymphoma? What are the normal functions of Myc?

6. List two similarities and two differences between HNPCC and FAP.

7. Describe mitochondria-regulated apoptosis. How does the mitochondria induce apoptosis? How does it inhibit apoptosis?

8. Describe the pathway by which mitogens control the rate of cell division.

9. A patient comes into the hospital that is found to have B cell lymphoma. Would you suggest traditional chemotherapy for this patient? Why or why not?

10. How does HPV activate cell proliferation?